Prevalence and Correlates of Any and Frequent Synthetic Cannabinoid Use in a Representative Sample of High School Students

References

• American Association of Poison Control Centers. (2015). Synthetic marijuana. Retrieved from http://www.aapcc.org/alerts/synthetic-marijuana/
   Google Scholar
• Barratt, M., Cakic, V., & Lenton, S. (2013). Patterns of synthetic cannabinoid use in Australia. Drug and Alcohol Review, 32(2), 141–146.
   PubMed Web of Science ®Google Scholar
• Brakoulias, V. (2012). Products containing synthetic cannabinoids and psychosis. Australian and New Zealand Journal of Psychiatry, 46(3), 281–282.
   PubMed Web of Science ®Google Scholar
• Castaneto, M., Gorelick, D., Desrosiers, N., Hartman, R., Pirard, S., & Huestis, M. (2014). Synthetic cannabinoids: Epidemiology, pharmacodynamics, and clinical implications. Drug And Alcohol Dependence, 144, 12–41.
   PubMed Web of Science ®Google Scholar
• Caviness, C., Tzilos, G., Anderson, B., & Stein, M. (2015). Synthetic cannabinoids: Use and predictors in a community sample of young adults. Substance Abuse, 36, 368–373.
   Google Scholar
• DeVore, E., & Ginsburg, K. (2005). The protective effects of good parenting on adolescents. Current Opinion in Pediatrics, 17(4), 460–465.
   PubMed Web of Science ®Google Scholar
• Every-Palmer, S. (2011). Synthetic cannabinoid JWH-018 and psychosis: An explorative study. Drug and Alcohol Dependence, 117(2), 152–157.
   PubMed Web of Science ®Google Scholar
• Fattore, L., & Fratta, W. (2011). Beyond THC: The new generation of cannabinoid designer drugs. Frontiers in Behavioral Neuroscience, 60(5), 1–12.
   Google Scholar
• Forrester, M., & Haywood, T. (2012). Geographic distribution of synthetic cannabinoid exposures reported to Texas poison centers. The American Journal of Drug and Alcohol Abuse, 38(6), 603–608.
   PubMed Web of Science ®Google Scholar
• Forrester, M., Kleinschmidt, K., Schwarz, E., & Young, A. (2012). Synthetic cannabinoid and marijuana exposures reported to poison centers. Human & Experimental Toxicology, 31(10), 1006–1011.
   PubMed Web of Science ®Google Scholar
• Hoyte, C., Jacob, J., Monte, A., Al-Jumaan, M., Bronstein, A., & Heard, K. (2012). A characterization of synthetic cannabinoid exposures reported to the National Poison Data System in 2010. Annals of Emergency Medicine, 60(4), 435–438.
   PubMed Web of Science ®Google Scholar
• Hu, X., Primack, B., Barnett, T., & Cook, R. (2011). College students and use of K2: An emerging drug of abuse in young persons. Substance Abuse Treatment Prevention Policy, 6(16), 1–4.
   Google Scholar
• Hurst, D., Loeffler, G., & McLay, R. (2011). Psychosis associated with synthetic cannabinoid agonists: A case series. American Journal of Psychiatry, 168(10), 1119.
   PubMed Web of Science ®Google Scholar
• Johnston, L. D., O'Malley, P. M., Miech, R. A., Bachman, J. G., & Schulenberg, J. E., (2015). Monitoring the Future national survey results on drug use, 1975–2014: Overview, key findings on adolescent drug use. Ann Arbor: Institute for Social Research, the University of Michigan.
   Google Scholar
• Kronstrand, R., Roman, M., Andersson, M., & Eklund, A. (2013). Toxicological findings of synthetic cannabinoids in recreational users. Journal of Analytical Toxicology, 37, 534–541.
   PubMed Web of Science ®Google Scholar
• Li, X., Stanton, B., & Feigelman, S. (2000). Impact of perceived parental monitoring on adolescent risk behavior over 4 years. Journal of Adolescent Health, 27(1), 49–56.
   PubMed Web of Science ®Google Scholar
• Miech, R. A., Johnston, L. D., O'Malley, P. M., Bachman, J. G., & Schulenberg, J. E. (2015). Monitoring the Future national survey results on drug use, 1975–2014: Volume I, Secondary school students. Ann Arbor: Institute for Social Research, The University of Michigan. Retrieved from http://monitoringthefuture.org/pubs.html#monographs
   Google Scholar
• Mir, A., Obafemi, A., Young, A., & Kane, C. (2011). Myocardial infarction associated with use of the synthetic cannabinoid K2. Pediatrics, 128(6), 1622–1627.
   Web of Science ®Google Scholar
• Moore, M., & Werch, C. (2005). Sport and physical activity participation and substance use among adolescents. Journal of Adolescent Health, 36, 486–493.
   PubMed Web of Science ®Google Scholar
• National Alliance for Model State Drug Laws. (2015). Synthetic and novel psychoactive substances. Retrieved from http://www.namsdl.org/synthetic-substances.cfm
   Google Scholar
• National Institute on Drug Abuse. (2003). Preventing drug use among children and adolescents. A research-based guide for parents, educators, and community leaders (2nd ed.). NIH Publication No. 04-4212(A). Bethesda, MD: U.S. Department of Health and Human Services.
   Google Scholar
• National Institute on Drug Abuse. (2012). Drug facts: Spice (“synthetic marijuana”). Retrieved from http://www.drugabuse.gov/publications/drugfacts/spice-synthetic-marijuana
   Google Scholar
• National Institute on Drug Abuse. (2015). K2/spice (“synthetic marijuana”). Retrieved from http://www.drugabuse.gov/drugs-abuse/k2spice-synthetic-marijuana
   Google Scholar
• Nevada Legislative Counsel Bureau. (2012). Research brief on methamphetamine, synthetic cannabinoids, and substituted cathinones. Retrieved from https://www.leg.state.nv.us/Division/Research/Publications/ResearchBriefs/Methamphetamine.pdf
   Google Scholar
• Oman, R., Vesely, S., Aspy, C., McLeroy, K., Rodine, S., & Marshall, L. (2004). The potential protective effect of youth assets on adolescent alcohol and drug use. American Journal of Public Health, 94(8), 1425–1430.
   PubMed Web of Science ®Google Scholar
• Palamar, J., & Acosta, P. (2015). Synthetic cannabinoid use in a nationally representative sample of US high school seniors. Drug and Alcohol Dependence, 149, 194–202.
   PubMed Web of Science ®Google Scholar
• Papanti, D., Schifano, F., Botteon, G., Bertossi, F., Mannix, J., Vidoni, D., . . . Bonavigo, T. (2013). “Spiceophrenia”: A systematic overview of “spice”-related psychopathological issues and a case report. Human Psychopharmacology Clinical and Experimental, 28(4), 379–389.
   PubMed Web of Science ®Google Scholar
• Rai, A., Stanton, B., Wu, Y., Li, X., Galbraith, J., & Cottrell, L., . . . Burns, J. (2003). Relative influences of perceived parental monitoring and perceived peer involvement on adolescent risk behaviors: An analysis of six cross-sectional data sets. Journal of Adolescent Health, 33(2), 108–118.
   PubMed Web of Science ®Google Scholar
• Stogner, J., & Miller, B. (2014). A spicy kind of high: A profile of synthetic cannabinoid users. Journal of Substance Abuse, 19(1–2), 199–205.
   Google Scholar
• Synthetic Drug Abuse Prevention Act of 2012, 21 U.S.C. § 1151 (2012). Retrieved from https://www.congress.gov/112/plaws/publ144/PLAW-112publ144.pdf
   Google Scholar
• United States Census Bureau. (2015). Urban and rural classification—Geography—U.S. Census Bureau. Retrieved from https://www.census.gov/geo/reference/urban-rural.html
   Google Scholar
• Wells, D., & Ott, C. (2011). The “new” marijuana. Annals of Pharmacotherapy, 45(3), 414–417.
   PubMed Web of Science ®Google Scholar
• Winstock, A., & Barratt, M. (2013a). Synthetic cannabis: A comparison of patterns of use and effect profile with natural cannabis in a large global sample. Drug and Alcohol Dependence, 131(1), 106–111.
   PubMed Web of Science ®Google Scholar
• Winstock, A., & Barratt, M. (2013b). The 12-month prevalence and nature of adverse experiences resulting in emergency medical presentations associated with the use of synthetic cannabinoid products. Human Psychopharmacology: Clinical and Experimental, 28(4), 390–393.
   PubMed Web of Science ®Google Scholar
• Wood, K. (2013). Exposure to bath salts and synthetic tetrahydrocannabinol from 2009 to 2012 in the United States. The Journal of Pediatrics, 163(1), 213–216.
   PubMed Web of Science ®Google Scholar